Article
Rapid detection of the epidermal growth factor receptor mutation in non-small-cell lung cancer for analysis of acquired resistance using molecular beacons.
The Journal of molecular diagnostics : JMD - 1 Sept 2010
Oh Young-Hee, Kim Youngwook, Kim Young-Pil, Seo Soo-Won, Mitsudomi Tetsuya, Ahn Myung-Ju, Park Keunchil, Kim Hak-Sung
Abstract excerpt
A secondary mutation (T790M) in epidermal growth factor receptor (EGFR) is a hallmark of acquired resistance to EGFR inhibitors used to treat non-small-cell lung cancer (NSCLC). Therefore, identifying the T790M mutation is crucial to guide treatment decisions. Given that DNA sequencing methods are time-consuming and insensitive, we developed and investigated the feasibility of using molecular beacons for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
